Annual CFI
$2.81 M
+$3.43 M+555.75%
31 March 2024
Summary:
Portage Biotech annual cash flow from investing activities is currently $2.81 million, with the most recent change of +$3.43 million (+555.75%) on 31 March 2024. During the last 3 years, it has risen by +$3.67 million (+426.98%). PRTG annual CFI is now -50.30% below its all-time high of $5.66 million, reached on 31 March 2018.PRTG Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
N/A
30 September 2024
Summary:
Portage Biotech quarterly cash flow from investing activities is not available.PRTG Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
N/A
30 September 2024
Summary:
Portage Biotech TTM cash flow from investing activities is not available.PRTG TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTG Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +555.8% | - | - |
| 3 y3 years | +427.0% | - | - |
| 5 y5 years | +730.5% | - | - |
PRTG Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +427.0% | ||||
| 5 y | 5 years | at high | +427.0% | ||||
| alltime | all time | -50.3% | +166.1% |
Portage Biotech Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $2.81 M(-555.8%) | $2.81 M(>+9900.0%) | $2.81 M(>+9900.0%) |
| Dec 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2023 | -$617.00 K(<-9900.0%) | $0.00(0.0%) | -$617.00 K(0.0%) |
| Dec 2022 | - | $0.00(-100.0%) | -$617.00 K(0.0%) |
| Sept 2022 | - | -$617.00 K(<-9900.0%) | -$617.00 K(<-9900.0%) |
| Mar 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2021 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2021 | -$860.00 K(<-9900.0%) | $0.00(0.0%) | -$860.00 K(0.0%) |
| Dec 2020 | - | $0.00(-100.0%) | -$860.00 K(0.0%) |
| Sept 2020 | - | $140.00 K(-114.0%) | -$860.00 K(-14.0%) |
| June 2020 | - | -$1.00 M(<-9900.0%) | -$1.00 M(<-9900.0%) |
| Mar 2020 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2019 | - | $0.00(0.0%) | $504.00 K(-213.0%) |
| Sept 2019 | - | $0.00(0.0%) | -$446.00 K(0.0%) |
| June 2019 | - | $0.00(-100.0%) | -$446.00 K(0.0%) |
| Mar 2019 | -$446.00 K(-107.9%) | $504.00 K(-153.1%) | -$446.00 K(-109.5%) |
| Dec 2018 | - | -$950.00 K(-116.8%) | $4.71 M(-16.8%) |
| Mar 2018 | $5.66 M(-266.0%) | $5.66 M(>+9900.0%) | $5.66 M(-266.0%) |
| Dec 2017 | - | $0.00(-100.0%) | -$3.41 M(0.0%) |
| Mar 2017 | -$3.41 M(+100.5%) | -$3.41 M(-440.9%) | -$3.41 M(<-9900.0%) |
| Sept 2016 | - | $1.00 M(-200.0%) | $0.00(-100.0%) |
| June 2016 | - | -$1.00 M(<-9900.0%) | -$2.70 M(+58.8%) |
| Mar 2016 | -$1.70 M(<-9900.0%) | $0.00(0.0%) | -$1.70 M(0.0%) |
| Dec 2015 | - | $0.00(-100.0%) | -$1.70 M(0.0%) |
| Sept 2015 | - | -$1.70 M(<-9900.0%) | -$1.70 M(<-9900.0%) |
| June 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2014 | $0.00(-100.0%) | - | - |
| Mar 2013 | $5.05 M(+381.5%) | -$68.30 K(+22.4%) | $5.05 M(-4.1%) |
| Dec 2012 | - | -$55.80 K(-133.4%) | $5.27 M(-7.3%) |
| Sept 2012 | - | $167.20 K(-96.7%) | $5.68 M(-2.1%) |
| June 2012 | - | $5.01 M(+3340.8%) | $5.81 M(+453.3%) |
| Mar 2012 | $1.05 M(+61.8%) | $145.60 K(-59.5%) | $1.05 M(-39.1%) |
| Dec 2011 | - | $359.20 K(+23.3%) | $1.72 M(+5.7%) |
| Sept 2011 | - | $291.40 K(+15.1%) | $1.63 M(+6.7%) |
| June 2011 | - | $253.20 K(-69.1%) | $1.53 M(+135.6%) |
| Mar 2011 | $648.40 K | $820.60 K(+208.8%) | $648.40 K(-93.2%) |
| Dec 2010 | - | $265.70 K(+41.0%) | $9.59 M(-294.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | $188.40 K(-130.1%) | -$4.93 M(-0.2%) |
| June 2010 | - | -$626.30 K(-106.4%) | -$4.94 M(+16.1%) |
| Mar 2010 | -$4.25 M(+796.3%) | $9.76 M(-168.5%) | -$4.25 M(-69.7%) |
| Dec 2009 | - | -$14.25 M(-8173.0%) | -$14.03 M(-6069.4%) |
| Sept 2009 | - | $176.50 K(+206.4%) | $235.10 K(-433.9%) |
| June 2009 | - | $57.60 K(-396.9%) | -$70.40 K(-85.2%) |
| Mar 2009 | -$474.60 K(-64.7%) | -$19.40 K(-195.1%) | -$474.60 K(-27.7%) |
| Dec 2008 | - | $20.40 K(-115.8%) | -$656.00 K(-45.9%) |
| Sept 2008 | - | -$129.00 K(-62.8%) | -$1.21 M(-19.6%) |
| June 2008 | - | -$346.60 K(+72.6%) | -$1.51 M(+12.2%) |
| Mar 2008 | -$1.34 M(+73.9%) | -$200.80 K(-62.6%) | -$1.34 M(+537.0%) |
| Dec 2007 | - | -$536.30 K(+26.2%) | -$211.00 K(-296.1%) |
| Sept 2007 | - | -$424.90 K(+133.3%) | $107.60 K(+454.6%) |
| June 2007 | - | -$182.10 K(-119.5%) | $19.40 K(-102.5%) |
| Mar 2007 | -$772.70 K(+28.7%) | $932.30 K(-528.2%) | -$772.80 K(-51.1%) |
| Dec 2006 | - | -$217.70 K(-57.6%) | -$1.58 M(+1.0%) |
| Sept 2006 | - | -$513.10 K(-47.3%) | -$1.57 M(+11.6%) |
| June 2006 | - | -$974.30 K(-888.3%) | -$1.40 M(+133.8%) |
| Mar 2006 | -$600.20 K(-68.9%) | $123.60 K(-161.3%) | -$600.10 K(-17.1%) |
| Dec 2005 | - | -$201.50 K(-42.5%) | -$723.70 K(+33.5%) |
| Sept 2005 | - | -$350.70 K(+104.5%) | -$542.20 K(+142.9%) |
| June 2005 | - | -$171.50 K(+757.5%) | -$223.20 K(-8.8%) |
| Dec 2004 | - | -$20.00 K(-36.9%) | -$244.70 K(-60.8%) |
| Sept 2004 | - | -$31.70 K(+2164.3%) | -$624.30 K(-67.7%) |
| June 2004 | - | -$1400.00(-99.3%) | -$1.93 M(+0.1%) |
| Mar 2004 | -$1.93 M(-5826.4%) | -$191.60 K(-52.1%) | -$1.93 M(+11.3%) |
| Dec 2003 | - | -$399.60 K(-70.1%) | -$1.73 M(+32.9%) |
| Sept 2003 | - | -$1.34 M(<-9900.0%) | -$1.30 M(-3971.8%) |
| June 2003 | - | $0.00(-100.0%) | $33.70 K(0.0%) |
| Mar 2003 | $33.70 K(+47.2%) | $3900.00(-86.9%) | $33.70 K(-56.3%) |
| Dec 2002 | - | $29.80 K(>+9900.0%) | $77.20 K(+65.7%) |
| Sept 2002 | - | $0.00(0.0%) | $46.60 K(+56.4%) |
| June 2002 | - | $0.00(-100.0%) | $29.80 K(+29.6%) |
| Mar 2002 | $22.90 K(-89.4%) | $47.40 K(-6025.0%) | $23.00 K(-194.3%) |
| Dec 2001 | - | -$800.00(-95.2%) | -$24.40 K(+3.4%) |
| Sept 2001 | - | -$16.80 K(+147.1%) | -$23.60 K(+247.1%) |
| June 2001 | - | -$6800.00 | -$6800.00 |
| Mar 2001 | $215.60 K(-3270.6%) | - | - |
| Mar 2000 | -$6800.00(-85.7%) | - | - |
| Mar 1999 | -$47.70 K(+5862.5%) | - | - |
| Mar 1998 | -$800.00 | - | - |
FAQ
- What is Portage Biotech annual cash flow from investing activities?
- What is the all time high annual CFI for Portage Biotech?
- What is Portage Biotech annual CFI year-on-year change?
- What is the all time high quarterly CFI for Portage Biotech?
- What is the all time high TTM CFI for Portage Biotech?
What is Portage Biotech annual cash flow from investing activities?
The current annual CFI of PRTG is $2.81 M
What is the all time high annual CFI for Portage Biotech?
Portage Biotech all-time high annual cash flow from investing activities is $5.66 M
What is Portage Biotech annual CFI year-on-year change?
Over the past year, PRTG annual cash flow from investing activities has changed by +$3.43 M (+555.75%)
What is the all time high quarterly CFI for Portage Biotech?
Portage Biotech all-time high quarterly cash flow from investing activities is $9.76 M
What is the all time high TTM CFI for Portage Biotech?
Portage Biotech all-time high TTM cash flow from investing activities is $9.59 M